Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative)

v3.24.2.u1
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 17, 2024
Nov. 17, 2023
Jun. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jun. 28, 2024
Derivative Instruments, Gain (Loss) [Line Items]                  
Stock issuance costs             $ 501,300    
Gain on exercise of series B warrants           $ 165,355 $ 0    
Series A And B Warrants [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Stock issuance costs         $ 1,451,249        
Series A Warrant [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Gross proceeds from issuance of equity   $ 10,990,530              
Closing price                 $ 4.28
Warrants, exercise price       $ 12.84   $ 12.84      
Warrants outstanding       5,527   5,527      
Warrant liability       $ 70,970   $ 70,970      
Series B Warrant [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Gross proceeds from issuance of equity   $ 3,345,961              
Closing price $ 28.90                
Warrants, exercise price $ 23.41                
Gain recognized on warrants       $ 5,096,488          
Loss recognized on warrants           $ 2,174,673      
Change in fair value of warrants $ 3,405,662                
May 2023 Notes [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Gain on fair value of conversion features     $ 5,792,788         $ 5,107,794